combination therapy with glp-1 receptor agonist and sglt2 inhibitor Frontiers SGLT2 Inhibitors vs. GLP-1 Agonists
Description
Gudbjrnsdottir et al
Prescription Type 20.4.5
In this study, male Sprague Dawley rats were trained to self-administer intravenous oxycodone under fixed ratio (FR) and PR schedules
Lancet 2008
The Bridge program will run through Dec
Clin Endocrinol (Oxf) 2017
